Day: April 14, 2021

Aligos Therapeutics Begins Dosing with Capsid Assembly Modulator Drug Candidate, ALG-000184, in First Cohort of Chronic Hepatitis B Patients in a Phase 1 Proof-of-Concept Study

Aligos now evaluating two of its four Chronic Hepatitis B (CHB) portfolio drug candidates in patientsSOUTH SAN FRANCISCO, Calif., April...

error: Content is protected !!